Screening for Caspase-3 Inhibitors: Effect of a Reducing Agent on Identified Hit Chemotypes
Ilya Okun1*,
Sergei Malarchuk2,
Elena Dubrovskaya2,
Alexander Khvat2,
Sergey Tkachenko2,
Volodymyr Kysil2,
Dmitry Kravchenko3,
Alexandre Ivachtchenko1
1 ChemDiv, Inc., San Diego, California.; Chemical Diversity Research Institute, Khimki, Moscow Region, Russia.
2 ChemDiv, Inc., San Diego, California.
3 Chemical Diversity Research Institute, Khimki, Moscow Region, Russia.
* To whom correspondence should be addressed. E-mail: io{at}chemdiv.com.
 |
Abstract |
|---|
When studying cysteinyl proteases in general and caspases in particular, it is generally accepted that a reaction buffer must contain a reducing agent to prevent essential cysteinyl groups from spontaneous oxidation. Dithiothreitol (DTT) and
-mercaptoethanol (
-MCE) are 2 of the most broadly used reducing agents. While screening a library of small molecules against caspase-3, the authors have found that the nature of the reducing agent used, DTT or
-MCE, dramatically affects screening results and leads to identification of nonoverlapping hits. Screening in DTT-containing buffer revealed few novel classes of small molecules that selectively and reversibly inhibit caspase-3 but failed to identify isatin sulfonamides recently found to be potent and selective caspase-3 inhibitors (false negatives). On the other hand, screening in the presence of
-MCE failed to identify a series of hit compounds, 1,3-dioxo-2,3-dichloro-1H-pyrrolo[3,4-c]quinolines, discovered with DTT, whereas isatin sulphonamides in these conditions exhibited strong caspase-3 inhibition. In this work, the authors show that thiol-containing reducing agents can affect catalytic activity of caspase-3 and modify its thermostability in a redox-potential-independent manner. The authors speculate that the differential structural modifications of caspase-3 seen with different reducing agents represent structurally different caspase-3 conformations and are responsible for its differential sensitivity to small molecules of different chemotypes. Hence, selection of the reducing agent may dramatically affect the quality of high-throughput screening campaigns.
Key Words:
caspase-3, inhibition, dithiothreitol,
-mercaptoethanol, redox potential, screening